Knowledge Center
Patent / Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Source:
WO 2013104892
The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.
Also in the Knowledge Center
/ Jan 01, 1989
Rhodium-containing hydrogenation catalysts for the conversion of methacycline to doxycycline
Read more
Scientific Article
/ Jan 01, 1989
Rhodium hydrogenation catalysts particularly for stereoselective hydrogenation of methacycline to doxycycline
Read more
Scientific Article
/ Jan 01, 1989
Homogeneous catalytic system for hydrogenation of methylenetetracyclines and a process for the preparation of same
Read more
Scientific Article